Correction: Intraovarian Platelet-Rich Plasma Injections: Safety and Thoughts on Efficacy Based on a Single Centre Experience With 469 Women
Mattheos Fraidakis, Giorgios Giannakakis, Aliki Anifantaki, Meltini Skouradaki, Paraskevi Tsakoumi, Popi Bitzopoulou, Sofia Kourpa, Alexandros Zervakis, Persefoni Kakouri
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPeriodontal Regeneration and Treatments · Platelet Disorders and Treatments · Blood transfusion and management
This article has been corrected to address the following errors:
Table 1: some FSH, E2 improvement percentages were incorrectly calculated due to an oversight in the initialization of the variables calculating the improvement percent of FSH, E2 of the custom script written for the analysis.
Results, paragraph 3: “Specifically, for the age range of 32-36” has been corrected to “Specifically, for the age range of 32-37”.
The authors deeply regret this oversight.